Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 265260, 16 pages
http://dx.doi.org/10.1155/2015/265260
Review Article

New Insights in the Diagnosis and Treatment of Heart Failure

1Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
2DIBINEM, University of Bologna, 40126 Bologna, Italy
3Heart Failure Unit, Cardiology Department, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy
4Department of Cardiovascular Surgery, University Hospital Lausanne, 1011 Lausanne, Switzerland
5Cardiac Surgery Unit, Department of Clinical and Experimental Medicine, University of Parma, Via A. Gramsci 14, 43126 Parma, Italy

Received 21 April 2015; Accepted 21 June 2015

Academic Editor: Maciej Banach

Copyright © 2015 Giulio Agnetti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Nicolini and T. Gherli, “Alternatives to transplantation in the surgical therapy for heart failure,” European Journal of Cardio-Thoracic Surgery, vol. 35, no. 2, pp. 214–228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Agnetti, C. Husberg, and J. E. van Eyk, “Divide and Conquer: the application of organelle proteomics to heart failure,” Circulation Research, vol. 108, no. 4, pp. 512–526, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Randell, “It's a MALDI but it's a goodie: Maldi-Tof mass spectrometry for microbial identification,” Thorax, vol. 69, no. 8, pp. 776–778, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Schechter, M. K. H. Hsieh, L. W. Njoroge et al., “Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure,” PLoS ONE, vol. 9, no. 8, Article ID e104157, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Hammer, M. Goritzka, S. Ameling et al., “Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies,” Journal of Proteome Research, vol. 10, no. 5, pp. 2161–2171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Su, H. Zhu, M. Zhang et al., “Salt-induced changes in cardiac phosphoproteome in a rat model of chronic renal failure,” PLoS ONE, vol. 9, no. 6, Article ID e100331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Agnetti, “Modified troponin I as a candidate marker for chronic heart failure: a top-down perspective,” Circulation: Cardiovascular Genetics, vol. 4, no. 5, pp. 579–580, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Agnetti, N. Kaludercic, L. A. Kane et al., “Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts,” Circulation: Cardiovascular Genetics, vol. 3, no. 1, pp. 78–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Zhang, J. A. Kirk, W. Ji et al., “Multiple reaction monitoring to identify site-specific troponin i phosphorylated residues in the failing human heart,” Circulation, vol. 126, no. 15, pp. 1828–1837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. S. Willis and C. Patterson, “Proteotoxicity and cardiac dysfunction—Alzheimer's disease of the heart?” The New England Journal of Medicine, vol. 368, no. 5, pp. 455–464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Sanbe, H. Osinska, J. E. Saffitz et al., “Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 27, pp. 10132–10136, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Agnetti, V. L. Halperin, J. A. Kirk et al., “Desmin modifications associate with amyloid-like oligomers deposition in heart failure,” Cardiovascular Research, vol. 102, no. 1, pp. 24–34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S. F. Mohammed, S. A. Mirzoyev, W. D. Edwards et al., “Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction,” JACC: Heart Failure, vol. 2, no. 2, pp. 113–122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Subramanian, D. Gianni, C. Balla et al., “Cofilin-2 phosphorylation and sequestration in myocardial aggregates: novel pathogenetic mechanisms for idiopathic dilated cardiomyopathy,” Journal of the American College of Cardiology, vol. 65, pp. 1199–1214, 2015. View at Google Scholar
  15. F. del Monte and G. Agnetti, “Protein post-translational modifications and misfolding: new concepts in heart failure,” Proteomics Clinical Applications, vol. 8, no. 7-8, pp. 534–542, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. T. N. Sidorova, L. V. Yermalitskaya, L. C. Mace et al., “Reactive γ-ketoaldehydes promote protein misfolding and preamyloid oligomer formation in rapidly-activated atrial cells,” Journal of Molecular and Cellular Cardiology, vol. 79, pp. 295–302, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Agnetti, “Mass spectrometry goes with the flow: mass cytometry and its potentials in regenerative medicine,” Circulation: Cardiovascular Genetics, vol. 5, no. 3, pp. 379–380, 2012. View at Publisher · View at Google Scholar
  18. T. Yoshizawa, T. Sakurai, A. Kamiyoshi et al., “Novel regulation of cardiac metabolism and homeostasis by the adrenomedullin-receptor activity-modifying protein 2 system,” Hypertension, vol. 61, no. 2, pp. 341–351, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Guo, P. Kouvonen, C. C. Koh et al., “Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps,” Nature Medicine, vol. 21, no. 4, pp. 407–413, 2015. View at Publisher · View at Google Scholar
  20. J. J. V. McMurray, S. Adamopoulos, S. D. Anker et al., “ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC,” European Heart Journal, vol. 33, no. 14, pp. 1787–1847, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Zannad, J. J. V. McMurray, H. Krum et al., “Eplerenone in patients with systolic heart failure and mild symptoms,” The New England Journal of Medicine, vol. 364, no. 1, pp. 11–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Swedberg, M. Komajda, M. Bohm et al., “Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study,” The Lancet, vol. 376, pp. 875–885, 2010. View at Google Scholar
  23. M. Packer, R. M. Califf, M. A. Konstam et al., “Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE),” Circulation, vol. 106, no. 8, pp. 920–926, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Komajda, S. D. Anker, A. Charlesworth et al., “The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET,” European Heart Journal, vol. 27, no. 12, pp. 1440–1446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. G. G. Sokos, L. A. Nikolaidis, S. Mankad, D. Elahi, and R. P. Shannon, “Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure,” Journal of Cardiac Failure, vol. 12, no. 9, pp. 694–699, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. B. M. Scirica, D. L. Bhatt, E. Braunwald et al., “Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus,” The New England Journal of Medicine, vol. 369, no. 14, pp. 1317–1326, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. W. B. White, C. P. Cannon, S. R. Heller et al., “Alogliptin after acute coronary syndrome in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 369, no. 14, pp. 1327–1335, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J. G. F. Cleland, M. Tendera, J. Adamus, N. Freemantle, L. Polonski, and J. Taylor, “The perindopril in elderly people with chronic heart failure (PEP-CHF) study,” European Heart Journal, vol. 27, no. 19, pp. 2338–2345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Yusuf, M. A. Pfeffer, K. Swedberg et al., “Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial,” The Lancet, vol. 362, no. 9386, pp. 777–781, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. B. M. Massie, P. E. Carson, J. J. McMurray et al., “Irbesartan in patients with heart failure and preserved ejection fraction,” The New England Journal of Medicine, vol. 359, no. 23, pp. 2456–2467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Komajda and C. S. P. Lam, “Heart failure with preserved ejection fraction: a clinical dilemma,” European Heart Journal, vol. 35, no. 16, pp. 1022–1032, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Gheorghiade, G. Sopko, L. De Luca et al., “Navigating the crossroads of coronary artery disease and heart failure,” Circulation, vol. 114, no. 11, pp. 1202–1213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. G. M. Felker, L. K. Shaw, and C. M. O'Connor, “A standardized definition of ischemic cardiomyopathy for use in clinical research,” Journal of the American College of Cardiology, vol. 39, no. 2, pp. 210–218, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. J. C. Manleu, J. F. King, and H. J. Zeft, “The ‘bad’ left ventricle: results of coronary surgery and effect on late survival,” Journal of Thoracic and Cardiovascular Surgery, vol. 72, no. 6, pp. 841–848, 1976. View at Google Scholar · View at Scopus
  35. R. E. Vlietstra, J. L. Assad-Morell, R. L. Frye et al., “Survival predictors in coronary artery disease. Medical and surgical comparisons,” Mayo Clinic Proceedings, vol. 52, no. 2, pp. 85–90, 1977. View at Google Scholar · View at Scopus
  36. S. L. Faulkner, W. S. Stoney, W. C. Alford et al., “Ischemic cardiomyopathy: medical versus surgical treatment,” Journal of Thoracic and Cardiovascular Surgery, vol. 74, no. 1, pp. 77–82, 1977. View at Google Scholar · View at Scopus
  37. E. L. Alderman, L. D. Fisher, P. Litwin et al., “Results of coronary artery surgery in patients with poor left ventricular function (CASS),” Circulation, vol. 68, no. 4, pp. 785–795, 1983. View at Publisher · View at Google Scholar · View at Scopus
  38. J. D. Pigott, N. T. Kouchoukos, A. Oberman, and G. R. Cutter, “Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function,” Journal of the American College of Cardiology, vol. 5, no. 5, pp. 1036–1045, 1985. View at Publisher · View at Google Scholar · View at Scopus
  39. E. P. Bounous, D. B. Mark, B. G. Pollock et al., “Surgical survival benefits for coronary disease patients with left ventricular dysfunction,” Circulation, vol. 78, no. 3, pp. I-151–I-157, 1988. View at Google Scholar · View at Scopus
  40. C. M. O'Connor, E. J. Velazquez, L. H. Gardner et al., “Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke cardiovascular disease databank),” American Journal of Cardiology, vol. 90, no. 2, pp. 101–107, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. E. J. Velazquez, J. B. Williams, E. Yow et al., “Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy,” Annals of Thoracic Surgery, vol. 93, no. 2, pp. 523–530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. “Eighteen-year follow-up in the veteran affairs cooperative study of coronary artery bypass surgery for stable angina. The VA Coronary Artery Bypass Surgery Cooperative Study Group,” Circulation, vol. 86, pp. 121–130, 1992.
  43. E. A. Caracciolo, K. B. Davis, G. Sopko et al., “Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience,” Circulation, vol. 91, no. 9, pp. 2335–2344, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. J. A. Elefteriades, D. L. Morales, C. Gradel, G. Tollis Jr., E. Levi, and B. L. Zaret, “Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions < or = 30%,” American Journal of Cardiology, vol. 79, pp. 1573–1578, 1997. View at Google Scholar
  45. S. P. Sedlis, K. B. Ramanathan, D. A. Morrison, G. Sethi, J. Sacks, and W. Henderson, “Department of veterans affairs cooperative study # 385, Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) investigators. Outcome of percutaneous coronary intervention versus coronary artery bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry),” The American Journal of Cardiology, vol. 94, pp. 118–120, 2004. View at Google Scholar
  46. W. Hueb, P. R. Soares, B. J. Gersh et al., “The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results,” Journal of the American College of Cardiology, vol. 43, no. 10, pp. 1743–1751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. W. E. Boden, R. A. O'Rourke, K. K. Teo et al., “Optimal medical therapy with or without PCI for stable coronary disease,” The New England Journal of Medicine, vol. 356, no. 15, pp. 1503–1516, 2007. View at Google Scholar
  48. R. L. Frye, P. August, M. M. Brooks et al., “A randomized trial of therapies for type 2 diabetes and coronary artery disease,” The New England Journal of Medicine, vol. 360, no. 24, pp. 2503–2515, 2009. View at Publisher · View at Google Scholar
  49. International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA), 2011, http://clinicaltrials.gov/show/NCT01471522.
  50. D. M. Bravata, K. M. McDonald, A. L. Gienger et al., “Comparative effectiveness of percutaneous coronary interventions and coronary artery bypass grafting for coronary artery disease,” AHRQ Comparative Effectiveness Reviews 9, Agency for Healthcare Research and Quality, Rockville, Md, USA, 2007. View at Google Scholar
  51. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators, “Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease,” The New England Journal of Medicine, vol. 335, no. 4, pp. 217–225, 1996. View at Publisher · View at Google Scholar
  52. D. A. Morrison, G. Sethi, J. Sacks et al., “Angina with Extremely Serious Operative Mortality Evaluation (AWESOME). Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina with Extremely Serious Operative Mortality Evaluation (AWESOME),” Journal of the American College of Cardiology, vol. 38, pp. 143–149, 2001. View at Google Scholar
  53. P. B. Berger, J. L. Velianou, H. Aslanidou Vlachos et al., “Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy: results from the bypass angioplasty revascularization investigation (BARI),” Journal of the American College of Cardiology, vol. 38, no. 5, pp. 1440–1449, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. P. W. Serruvs, M.-C. Morice, A. P. Kappetein et al., “Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease,” The New England Journal of Medicine, vol. 360, no. 10, pp. 961–972, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. M. E. Farkouh, M. Domanski, L. A. Sleeper et al., “Strategies for multivessel revascularization in patients with diabetes,” The New England Journal of Medicine, vol. 367, pp. 2375–2384, 2012. View at Publisher · View at Google Scholar
  56. E. J. Velazquez, K. L. Lee, C. M. O'Connor et al., “The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial,” The Journal of Thoracic and Cardiovascular Surgery, vol. 134, no. 6, pp. 1540–1547, 2007. View at Google Scholar
  57. E. J. Velazquez, K. L. Lee, M. A. Deja et al., “Coronary-artery bypass surgery in patients with left ventricular dysfunction,” The New England Journal of Medicine, vol. 364, no. 17, pp. 1607–1616, 2011. View at Publisher · View at Google Scholar
  58. T. Doenst, J. G. F. Cleland, J. L. Rouleau et al., “Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease,” Circulation: Heart Failure, vol. 6, no. 3, pp. 443–450, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. R. A. H. Stewart, D. Szalewska, L. She et al., “Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH Trial,” Journal of the American College of Cardiology: Heart Failure, vol. 2, pp. 335–343, 2014. View at Google Scholar
  60. J. A. Panza, E. J. Velazquez, L. She et al., “Extent of coronary and myocardial disease and benefit from surgical revascularization in LV dysfunction,” Journal of the American College of Cardiology, vol. 64, no. 6, pp. 553–561, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. C. L. Athanasuleas, G. D. Buckberg, A. W. H. Stanley et al., “Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation,” Journal of the American College of Cardiology, vol. 44, no. 7, pp. 1439–1445, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Yamaguchi, H. Adachi, K. Kawahito, S. Murata, and T. Ino, “Left ventricular reconstruction benefits patients with dilated ischemic cardiomyopathy,” Annals of Thoracic Surgery, vol. 79, no. 2, pp. 456–461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Menicanti, S. Castelvecchio, M. Ranucci et al., “Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration,” Journal of Thoracic and Cardiovascular Surgery, vol. 134, no. 2, pp. 433.e2–341.e2, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. V. Dor, M. Saab, P. Coste, M. Kornaszewska, and F. Montiglio, “Left ventricular aneurysm: a new surgical approach,” The Thoracic and Cardiovascular Surgeon, vol. 37, no. 1, pp. 11–19, 1989. View at Publisher · View at Google Scholar · View at Scopus
  65. V. Dor, M. Sabatier, M. Di Donato, M. Maioli, A. Toso, and F. Montiglio, “Late hemodynamic results after left ventricular patch repair associated with coronary grafting in patients with postinfarction akinetic or dyskinetic aneurysm of the left ventricle,” The Journal of Thoracic and Cardiovascular Surgery, vol. 110, no. 5, pp. 1291–1301, 1995. View at Publisher · View at Google Scholar · View at Scopus
  66. R. H. Jones, E. J. Velazquez, R. E. Michler et al., “Coronary bypass surgery with or without surgical ventricular reconstruction,” The New England Journal of Medicine, vol. 360, no. 17, pp. 1705–1717, 2009. View at Publisher · View at Google Scholar
  67. D. B. Mark, J. D. Knight, E. J. Velazquez et al., “Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial,” American Heart Journal, vol. 157, no. 5, pp. 837.e3–844.e3, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. R. G. Walsh, “Design and features of the Acorn CorCap Cardiac Support Device: the concept of passive mechanical diastolic support,” Heart Failure Reviews, vol. 10, no. 2, pp. 101–107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. D. L. Mann, M. A. Acker, M. Jessup, H. N. Sabbah, R. C. Starling, and S. H. Kubo, “Clinical evaluation of the corcap cardiac support device in patients with dilated cardiomyopathy,” Annals of Thoracic Surgery, vol. 84, no. 4, pp. 1226–1235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. R. C. Starling, M. Jessup, J. K. Oh et al., “Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial,” The Annals of Thoracic Surgery, vol. 84, no. 4, pp. 1236–1242, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. D. L. Mann, S. H. Kubo, H. N. Sabbah et al., “Beneficial effects of the CorCap cardiac support device: five-year results from the Acorn Trial,” Journal of Thoracic and Cardiovascular Surgery, vol. 143, no. 5, pp. 1036–1042, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Fukamachi and P. M. McCarthy, “Initial safety and feasibility clinical trial of the myosplint device,” Journal of Cardiac Surgery, vol. 20, no. 6, pp. S43–S47, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Fukamachi, M. Inoue, Z. Popović et al., “Optimal mitral annular and subvalvular shape change created by the Coapsys device to treat functional mitral regurgitation,” ASAIO Journal, vol. 51, no. 1, pp. 17–21, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. E. A. Grossi, N. Patel, Y. J. Woo et al., “Outcomes of the RESTOR-MV Trial (randomized evaluation of a surgical treatment for off-pump repair of the mitral valve),” Journal of the American College of Cardiology, vol. 56, no. 24, pp. 1984–1993, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Sharkey, S. Nikolic, A. Khairkhahan, and M. Dae, “Left ventricular apex occluder. Description of a ventricular partitioning device,” EuroIntervention, vol. 2, pp. 125–127, 2006. View at Google Scholar
  76. S. D. Nikolic, A. Khairkhahan, M. Ryu, G. Champsaur, E. Breznock, and M. Dae, “Percutaneous implantation of an intraventricular device for the treatment of heart failure: experimental results and proof of concept,” Journal of Cardiac Failure, vol. 15, no. 9, pp. 790–797, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. E. L. Mazzaferri Jr., S. Gradinac, D. Sagic et al., “Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial,” American Heart Journal, vol. 163, no. 5, pp. 812.e1–820.e1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Vahanian, O. Alfieri, F. Andreotti et al., “Guidelines on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS''),” European Journal Cardio-Thoracic Surgery, vol. 42, pp. S1–S44, 2012. View at Google Scholar
  79. R. O. Bonow, B. A. Carabello, K. Chatterjee et al., “2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to develop guidelines for the management of patients with valvular heart disease),” Journal of the American College of Cardiology, vol. 52, pp. e1–e142, 2008. View at Google Scholar
  80. T. G. Di Salvo, M. A. Acker, G. W. Dec, and J. G. Byrne, “Mitral valve surgery in advanced heart failure,” Journal of the American College of Cardiology, vol. 55, no. 4, pp. 271–282, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. W. Bouma, I. C. C. van der Horst, I. J. Wijdh-den Hamer et al., “Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches,” European Journal of Cardio-Thoracic Surgery, vol. 37, no. 1, pp. 170–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. B. A. Carabello, “Ischemic mitral regurgitation and ventricular remodeling,” Journal of the American College of Cardiology, vol. 43, no. 3, pp. 384–385, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. A. H. Wu, K. D. Aaronson, S. F. Bolling, F. D. Pagani, K. Welch, and T. M. Koelling, “Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction,” Journal of the American College of Cardiology, vol. 45, no. 3, pp. 381–387, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. D.-H. Kang, M.-J. Kim, S.-J. Kang et al., “Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation,” Circulation, vol. 114, no. 1, pp. 499–503, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. D. R. Wong, A. K. Agnihotri, J. W. Hung et al., “Long-term survival after surgical revascularization for moderate ischemic mitral regurgitation,” Annals of Thoracic Surgery, vol. 80, no. 2, pp. 570–577, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Goland, L. S. C. Czer, R. J. Siegel et al., “Coronary revascularization alone or with mitral valve repair: outcomes in patients with moderate ischemic mitral regurgitation,” Texas Heart Institute Journal, vol. 36, no. 5, pp. 416–424, 2009. View at Google Scholar · View at Scopus
  87. A. Trento, S. Goland, M. A. De Robertis, and L. S. C. Czer, “Counterpoint: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation,” Journal of Thoracic and Cardiovascular Surgery, vol. 138, no. 2, pp. 286–288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. B. H. Trichon, D. D. Glower, L. K. Shaw et al., “Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation,” Circulation, vol. 108, no. 10, pp. II103–II110, 2003. View at Google Scholar · View at Scopus
  89. M. H. Kwon, M. Cevasco, and F. Y. Chen, “Functional, ischemic mitral regurgitation. To repair or not to repair?” Circulation, vol. 125, no. 21, pp. 2563–2565, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. M. A. Deja, P. A. Grayburn, B. Sun et al., “Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial,” Circulation, vol. 125, no. 21, pp. 2639–2648, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. K. M. J. Chan, P. P. Punjabi, M. Flather et al., “Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial,” Circulation, vol. 126, no. 21, pp. 2502–2510, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. M. A. Romano and S. F. Bolling, “Update on mitral repair in dilated cardiomyopathy,” Journal of Cardiac Surgery, vol. 19, no. 5, pp. 396–400, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. K. Takeda, K. Taniguchi, Y. Shudo et al., “Mechanism of beneficial effects of restrictive mitral annuloplasty in patients with dilated cardiomyopathy and functional mitral regurgitation,” Circulation, vol. 122, no. 11, pp. S3–S9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. E. A. ten Brinke, R. J. Klautz, S. A. Tulner et al., “Clinical and functional effects of restrictive mitral annuloplasty at midterm follow-up in heart failure patients,” Annals of Thoracic Surgery, vol. 90, no. 6, pp. 1913–1920, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. K. Takeda, T. Sakaguchi, S. Miyagawa et al., “The extent of early left ventricular reverse remodelling is related to midterm outcomes after restrictive mitral annuloplasty in patients with non-ischaemic dilated cardiomyopathy and functional mitral regurgitation,” European Journal of Cardio-Thoracic Surgery, vol. 41, no. 3, pp. 506–511, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Auricchio, W. Schillinger, S. Meyer et al., “Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling,” Journal of the American College of Cardiology, vol. 58, no. 21, pp. 2183–2189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. G. Nickenig, R. Estevez-Loureiro, O. Franzen et al., “Percutaneous mitral valve edge-to-edge Repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 pilot European Sentinel Registry,” Journal of the American College of Cardiology, vol. 64, no. 9, pp. 875–884, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. M. J. Swaans, A. L. M. Bakker, A. Alipour et al., “Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients,” JACC: Cardiovascular Interventions, vol. 7, no. 8, pp. 875–881, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. COAPT Clinical Trial, 2012, http://clinicaltrials.gov/show/NCT01626079.
  100. A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation (RESHAPE-HF), 2013, http://clinicaltrials.gov/show/NCT01772108.
  101. D. O. Taylor, L. B. Edwards, P. J. Mohacsi et al., “The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report—2003,” Journal of Heart and Lung Transplantation, vol. 22, no. 6, pp. 616–624, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. E. A. Rose, A. C. Gelijns, A. J. Moskowitz et al., “Long-term use of a left ventricular assist device for end-stage heart failure,” The New England Journal of Medicine, vol. 345, no. 20, pp. 1435–1443, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. L. W. Stevenson and R. L. Kormos, “Mechanical cardiac support 2000: current applications and future trial design,” Journal of the American College of Cardiology, vol. 37, no. 1, pp. 340–370, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. D. Timms, M. Hayne, K. McNeil, and A. Galbraith, “A complete mock circulation loop for the evaluation of left, right, and biventricular assist devices,” Artificial Organs, vol. 29, no. 7, pp. 564–572, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. G. M. Pantalos, S. C. Koenig, K. J. Gillars, G. A. Giridharan, and D. L. Ewert, “Characterization of an adult mock circulation for testing cardiac support devices,” ASAIO Journal, vol. 50, no. 1, pp. 37–46, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. Y. Liu, P. Allaire, H. Wood, and D. Olsen, “Design and initial testing of a mock human circulatory loop for left ventricular assist device performance testing,” Artificial Organs, vol. 29, no. 4, pp. 341–345, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. P. Swier, W. J. Bos, S. F. Mohammad, D. B. Olsen, and W. J. Kolff, “An in vitro test model to study the performance and thrombogenecity of cardiovascular devices,” ASAIO Transactions, vol. 35, no. 3, pp. 683–687, 1989. View at Publisher · View at Google Scholar · View at Scopus
  108. C. M. Terracciano, L. W. Miller, and M. H. Yacoub, “Contemporary use of ventricular assist devices,” Annual Review of Medicine, vol. 61, pp. 255–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. S. R. Wilson, M. M. Givertz, G. C. Stewart, and G. H. Mudge, “Ventricular assist devices, the challenges of outpatient management,” Journal of the American College of Cardiology, vol. 54, no. 18, pp. 1647–1659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. C. Freitas De Souza, F. De Souza Brito, V. Correia Lima, and A. C. De Camargo Carvalho, “Percutaneous mechanical assistance for the failing heart,” Journal of Interventional Cardiology, vol. 23, no. 2, pp. 195–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. N. Mitter and R. Sheinberg, “Update on ventricular assist devices,” Current Opinion in Anaesthesiology, vol. 23, no. 1, pp. 57–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. F. Kadmar, A. Boyle, K. Liao, M. Colvin-Adams, L. Joyce, and R. John, “Effect of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients,” The Journal of Heart and Lung Transplantation, vol. 28, pp. 352–359, 2009. View at Google Scholar
  113. S. Garcia, F. Kandar, A. Boyle et al., “Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading,” Journal of Heart and Lung Transplantation, vol. 27, no. 3, pp. 261–267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Klotz, M. C. Deng, J. Stypmann et al., “Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support,” The Annals of Thoracic Surgery, vol. 77, no. 1, pp. 143–150, 2004. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Muradbegovic, S. Taub, E. Rizzo, L. K. Von Segesser, and P. Tozzi, “Experimental test bench for pediatric biventricular assist device based on artificial muscles for external heart compression,” ASAIO Journal, vol. 57, no. 1, pp. 62–67, 2011. View at Google Scholar
  116. J. G. Rogers, K. D. Aaronson, A. J. Boyle et al., “Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients,” Journal of the American College of Cardiology, vol. 55, no. 17, pp. 1826–1834, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. F. D. Pagani, L. W. Miller, S. D. Russell et al., “Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device,” Journal of the American College of Cardiology, vol. 54, no. 4, pp. 312–321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. J. R. Fitzpatrick III, J. R. Frederick, W. Hiesinger et al., “Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device,” Journal of Thoracic and Cardiovascular Surgery, vol. 137, no. 4, pp. 971–977, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. P. Tozzi, “Artificial muscle: the human chimera is the future,” Swiss Medical Weekly, vol. 141, Article ID w13311, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Michalis, P. Tozzi, M. Burki, D. Berdajs, S. Taub, and L. K. Von Segesser, Nitinol Based Artificial Muscle Independent Biventricular External Cardiac Assist Device: Bench Test Results, Sous presse, 2010.
  121. Y. Suzuki, K. Daitoku, M. Minakawa, K. Fukui, and I. Fukuda, “Dynamic cardiomyoplasty using artificial muscle,” Journal of Artificial Organs, vol. 11, no. 3, pp. 160–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  122. E. Abdelnour-Berchtold, P. Tozzir, G. Siniscalchi, D. Hayoz, and L. K. von Segesser, “Atrial assist device, a new alternative to lifelong anticoagulation?” Swiss Medical Weekly, vol. 139, no. 5-6, pp. 82–87, 2009. View at Google Scholar · View at Scopus
  123. P. Tozzi, A. Michalis, D. Hayoz, D. Locca, and L. K. von Segesser, “Artificial muscle for end-stage heart failure,” ASAIO Journal, vol. 58, no. 2, pp. 103–108, 2012. View at Publisher · View at Google Scholar · View at Scopus